Similar articles

• New oral anticoagulants in acute coronary syndromes: what does a meta-analysis tell us?

  Kwong JS, Yu CM. Kwong JS, et al. JAMA Intern Med. 2013 May 13;173(9):834-5. doi: 10.1001/jamainternmed.2013.78. JAMA Intern Med. 2013. PMID: 23700019 No abstract available.
• New oral anticoagulants in acute coronary syndromes: what does a meta-analysis tell us?--Reply.

  Komócsi A, Vorobcsuk A, Aradi D. Komócsi A, et al. JAMA Intern Med. 2013 May 13;173(9):835. doi: 10.1001/jamainternmed.2013.424. JAMA Intern Med. 2013. PMID: 23700020 No abstract available.
• Use of new-generation oral anticoagulant agents in patients receiving antiplatelet therapy after an acute coronary syndrome: systematic review and meta-analysis of randomized controlled trials.

  Komócsi A, Vorobcsuk A, Kehl D, Aradi D. Komócsi A, et al. Arch Intern Med. 2012 Nov 12;172(20):1537-45. doi: 10.1001/archinternmed.2012.4026. Arch Intern Med. 2012. PMID: 23007264 Review.
• Balancing hemostasis and thrombosis in interventional vascular medicine and surgery.

  Buergler JM, Kleiman NS. Buergler JM, et al. Methodist Debakey Cardiovasc J. 2011 Oct-Dec;7(4):19-23. doi: 10.14797/mdcj-7-4-19. Methodist Debakey Cardiovasc J. 2011. PMID: 22143472 Review.
• Novel oral anticoagulants and gastrointestinal bleeding: a case for cardiogastroenterology.

  Abraham NS. Abraham NS. Clin Gastroenterol Hepatol. 2013 Apr;11(4):324-8. doi: 10.1016/j.cgh.2012.12.013. Epub 2013 Jan 21. Clin Gastroenterol Hepatol. 2013. PMID: 23348145 No abstract available.